$3.86

-0.06 (-1.53%)

9/5/2008 3:46 PM

Helicos BioSciences Corp. (HLCS)

CAPS Rating:

Helicos is a life sciences company focused on innovative genetic analysis technologies for the research, drug discovery and clinical diagnostics markets.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

Ticker Not Ratable

HLCS doesn't currently meet the $100M market cap / $1.50 stock price minimum. (Learn More)

What the Community Thinks

Total Members

50 Outperforms

17 Underperforms

All-Stars

9 Outperforms

6 Underperforms

Wall Street

3 Outperforms

0 Underperforms

Members bullish on HLCS are also bullish on:

Members bearish on HLCS are also bearish on:

Ticker Tags

Drugs - Generic (14), IPO in 2007 (239), Micro Cap (4824)
Suggest a tag

Helicos BioSciences Corp. At A Glance

Current Price:	$3.86
Last Trade Time:	9/5/2008 3:46 PM
Open:	$3.89
Previous Close:	$3.92
Daily Range:	$3.86 - $3.93
52-Week Range:	$3.74 - $18.60
Volume:	3,550
Market Cap:	$82.79M
P/E Ratio:	3.73
Compare Our Special Broker Offers!

Stock Trends

HLCS VS S&P 500 (SPY)

News & Discussion Boards

Sorry no news articles available for HLCS.

Top Bull Pitch

Recs

6 Helicos BioSciences Corp. (HLCS)

Avatar eboniecat100 (< 20) Submitted: 12/30/07 12:18 PM

Helicos BioSciences Corporation (HLCS)

A money-losing, high-tech start-up participating in a highly-competitive race for the $1,000 genome – what’s there to like. Actually, quite a bit.

Bullish Argument: The World’s First Single Molecule Genetic Analyzer – for everyone who isn’t a molecular biol...More

Replies: 0 | Reply | Permalink

Helicos BioSciences Corporation (HLCS)

A money-losing, high-tech start-up participating in a highly-competitive race for the $1,000 genome – what’s there to like. Actually, quite a bit.

Bullish Argument: The World’s First Single Molecule Genetic Analyzer – for everyone who isn’t a molecular biologist, this is a dramatically faster way of decoding a genome. The Human Genome Project took 7 years and about $30 million, this technology can do a human genome in 10-16 days for about $100,000; with the potential of doing a human genome in 24-hours for $1,000. Helicos states that they will be shipping their first commercial product (hand-assembled) in first quarter 2008 and that they are projecting automated production in first quarter 2009. Each machine also generates a continuing revenue stream from reagents and disposables that are used in each genome analysis. They have experienced management, starting with a CEO/Chairman who has founded two public diagnostic companies. On the technical analysis side, the stock currently seems to be in a range from about $9.50 to $11.00. It’s peak was about $, prior to announcing a delay in delivering their first commercial unit and a downgrade by UBS. It closed Friday 12/28/07 at $10.29 a share.

Bearish Argument: They delayed first commercial delivery once and cancelled a major presentation on their technology at the GME Conference in October 2007 with no explanation. Are they still resolving technical problems? Will they delay commercial delivery again? They have enough cash to continue operations for one year and they state they anticipate needing additional financing (bonds or stock) in Summer 2008.

I regard this as a highly speculative stock, but I will be trying to build a small position around $10 per share. If the tech pans out this could be a big home run, indeed once they finally deliver their first commercial product we could easily seem them retesting their all time highs. But, if they don’t deliver by March or April, it could well be time to run for the exits.

Top Bear Pitch

Recs

3 Helicos BioSciences Corp. (HLCS)

Avatar 21popsontop (20.35) Submitted: 1/15/08 12:53 PM

OK,so they get 20 million line of credit. They already owe dept,have no real way to make money,even the analyst following the company have noted that with full year 2007 EPS minus - $2.88 and they could not even meet the loss. Full year 2008,which I can't see them staying in business that long,but a...More

Replies: 0 | Reply | Permalink

CAPS Members

Show Me:

Sort by:

picks per page. CHANGE

Results 1 - 5 of 15 : 1 2 3 Next »

Recs 0 (HLCS) Peluche99 (< 20) Submitted: 7/01/08 3:09 PM : Start Price: $5.07 HLCS Score: -16.06 i'm taking a second mortgage out on the house just so i can own a few shares of this company. Thats how much i believe in it. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (HLCS) Robyn9280 (< 20) Submitted: 5/08/08 1:59 PM : Start Price: $5.90 HLCS Score: -23.31 Helicos BioSciences Corporation, a life sciences company, engages in the development of genetic analysis technologies for the research, drug discovery, and clinical diagnostics markets. The company's Helicos genetic analysis platform consists of HeliScope single molecule sequencer an image analysis computer tower called the HeliScope analysis engine, associated reagents, which are chemicals used in the sequencing process, and disposable supplies. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (HLCS) dontwannabebroke (< 20) Submitted: 5/08/08 9:53 AM : Start Price: $6.00 HLCS Score: -24.56 Moving from R&D to sales. These instruments could be in high demand. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (HLCS) geilfuss (< 20) Submitted: 4/14/08 12:06 PM : Start Price: $8.18 HLCS Score: 44.08 Will do better near future Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (HLCS) Ajiday (51.16) Submitted: 4/04/08 7:25 AM : Start Price: $8.15 HLCS Score: -44.12 Health and affiliated industries will only get better, as more people live longer and require medical care and support. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Results 1 - 5 of 15 : 1 2 3 Next »

Wall Street

Results 1 - 3 of 3

picks per page. CHANGE

Top Pick	Member Name	Member Rating	Start Date	Call	Time Frame	Start Price	Stock Gain	S&P Gain	Score	Pitch
	TrackCantorFitz	90.88	03/20/08		NS	$6.07	-36.41%	-4.33%	-32.08
	TrackPacificGrow	77.92	07/05/07		NS	$8.92	-56.73%	-18.19%	-38.54
	TrackLeerinkSwan	99.10	07/05/07		NS	$8.98	-57.02%	-18.39%	-38.63

Results 1 - 3 of 3

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.